Posts in tag
cancer treatment
Innocrin Pharmaceuticals Inks $28M in Series D
What does Innocrin Pharmaceuticals do? Innocrin Pharmaceuticals, is a pharmaceutical company, which discovers and develops oral inhibitors for the treatment of castration- resistant prostate cancer and best in class oral inhibitors of CYP17 lyase, which is a validated enzyme target for the treatment and for hormone driven conditions such as endometriosis, breast cancer and congenial …